{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-24-000069","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.172394+00:00","generated_at":"2026-05-31T16:46:10.589366+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Edwards Q2 revenue +8% CC, TAVR guidance cut to 5-7%; announces $1.2B in acquisitions","bullets":["Q2 continuing ops sales $1.35B (+7% reported, +8% CC); adj. EPS $0.70, GAAP EPS $0.61.","TAVR sales $1.0B, growth 5% (6% CC); FY2024 TAVR guidance lowered to 5-7% from 8-10%.","TMTT sales $83M, +75%; FY2024 TMTT guidance raised to high end of $320-340M range.","Entered agreement to acquire JenaValve (aortic regurgitation) and exercised option to acquire Endotronix (PA pressure sensor); total upfront ~$1.2B cash plus up to $445M milestones.","Critical Care sale ($4.2B) on track to close late Q3 2024; Q3 sales guidance $1.56-1.64B, EPS $0.67-0.71."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-24-000069","json":"https://secwatch.observer/filing/0001099800-24-000069.json","markdown":"https://secwatch.observer/filing/0001099800-24-000069.md","text":"https://secwatch.observer/filing/0001099800-24-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000069/0001099800-24-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000069/ew-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:46:10.589366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}